Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil-DNA glycosylase

Non-reproducible sequence artefacts are frequently detected in DNA from formalin-fixed and paraffin-embedded (FFPE) tissues. However, no rational strategy has been developed for reduction of sequence artefacts from FFPE DNA as the underlying causes of the artefacts are poorly understood. As cytosine deamination to uracil is a common form of DNA damage in ancient DNA, we set out to examine whether treatment of FFPE DNA with uracil-DNA glycosylase (UDG) would lead to the reduction of C>T (and G>A) sequence artefacts. Heteroduplex formation in high resolution melting (HRM)-based assays was used for the detection of sequence variants in FFPE DNA samples. A set of samples that gave false positive HRM results for screening of the E17K mutation in exon 4 of the AKT1 gene were chosen for analysis. Sequencing of these samples showed multiple non-reproducible C:G>T:A artefacts. Treatment of the FFPE DNA with UDG prior to PCR amplification led to a very marked reduction of the sequence artefacts as indicated by both HRM and sequencing analysis. Similar results were shown for the BRAFV600 region in the same sample set and EGFR exon 19 in another sample set. UDG treatment specifically suppressed the formation of artefacts in FFPE DNA as it did not affect the detection of true KRAS codon 12 and true EGFR exon 19 and 20 mutations. We conclude that uracil in FFPE DNA leads to a significant proportion of sequence artefacts. These can be minimised by a simple UDG pre-treatment, which can be readily carried out in the same tube as the PCR, immediately prior to commencing thermal cycling. HRM is a convenient way of monitoring both the degree of damage and the effectiveness of the UDG treatment. These findings have immediate and important implications for cancer diagnostics where FFPE DNA is used as the primary genetic material for mutational studies guiding personalised medicine strategies and where simple effective strategies to detect mutations are required.

[1]  Adrian W. Briggs,et al.  Road blocks on paleogenomes—polymerase extension profiling reveals the frequency of blocking lesions in ancient DNA , 2010, Nucleic acids research.

[2]  Philip L. F. Johnson,et al.  Patterns of damage in genomic DNA sequences from a Neandertal , 2007, Proceedings of the National Academy of Sciences.

[3]  F. Pontén,et al.  A high frequency of sequence alterations is due to formalin fixation of archival specimens. , 1999, The American journal of pathology.

[4]  D. Primerano,et al.  Effect of DNA damage on PCR amplification efficiency with the relative threshold cycle method. , 2004, Biochemical and biophysical research communications.

[5]  G. Giaccone,et al.  EGFR and K-ras Mutation Analysis in Non-Small Cell Lung Cancer: Comparison of Paraffin Embedded versus Frozen Specimens , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[6]  A. von Haeseler,et al.  DNA sequences from multiple amplifications reveal artifacts induced by cytosine deamination in ancient DNA. , 2001, Nucleic acids research.

[7]  Carl T Wittwer,et al.  High-resolution DNA melting analysis in clinical research and diagnostics , 2010, Expert review of molecular diagnostics.

[8]  S. Fox,et al.  Detection of the transforming AKT1 mutation E17K in non-small cell lung cancer by high resolution melting , 2008, BMC Research Notes.

[9]  Adrian W. Briggs,et al.  Targeted Retrieval and Analysis of Five Neandertal mtDNA Genomes , 2009, Science.

[10]  D. Shibata,et al.  In vitro mutation artifacts after formalin fixation and error prone translesion synthesis during PCR , 2004, BMC clinical pathology.

[11]  S. Fox,et al.  High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies , 2008, BMC Cancer.

[12]  H. Do,et al.  Rarity of AKT1 and AKT3 E17K mutations in squamous cell carcinoma of lung , 2010, Cell cycle.

[13]  Alan Ashworth,et al.  Translating cancer research into targeted therapeutics , 2010, Nature.

[14]  J.,et al.  The New England Journal of Medicine , 2012 .

[15]  T. Lindahl.  Instability and decay of the primary structure of DNA , 1993, Nature.

[16]  F. André,et al.  Molecular circuits of solid tumors: prognostic and predictive tools for bedside use , 2010, Nature Reviews Clinical Oncology.

[17]  T. Frebourg,et al.  Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls , 2011, Modern Pathology.

[18]  H. Krokan,et al.  The interacting pathways for prevention and repair of oxidative DNA damage. , 2003, Mutation research.

[19]  J. Halgunset,et al.  Low copy number DNA template can render polymerase chain reaction error prone in a sequence-dependent manner. , 2005, The Journal of molecular diagnostics : JMD.

[20]  David M. Thomas,et al.  High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer , 2006, BMC Cancer.

[21]  A. Marchetti,et al.  Assessing EGFR mutations. , 2006, The New England journal of medicine.

[22]  J. Solassol,et al.  KRAS Mutation Detection in Paired Frozen and Formalin-Fixed Paraffin-Embedded (FFPE) Colorectal Cancer Tissues , 2011, International journal of molecular sciences.

[23]  James Denvir,et al.  DNA damage reduces Taq DNA polymerase fidelity and PCR amplification efficiency. , 2007, Biochemical and biophysical research communications.

[24]  M. Beaumont,et al.  Novel high-resolution characterization of ancient DNA reveals C > U-type base modification events as the sole cause of post mortem miscoding lesions , 2007, Nucleic acids research.

[25]  J. Hartley,et al.  Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. , 1990, Gene.

[26]  B. Werness,et al.  Mutations in BRCA1 from fixed, paraffin-embedded tissue can be artifacts of preservation. , 1998, Cancer genetics and cytogenetics.

[27]  Issa J Dahabreh,et al.  Somatic Mutations of the Tyrosine Kinase Domain of Epidermal Growth Factor Receptor and Tyrosine Kinase Inhibitor Response to TKIs in Non-small Cell Lung Cancer: An Analytical Database , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.